Clinical Trials Conditions Events Sleep 
Project CBD
MAY 3, 2023
And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. CannMed: For what conditions do you think CBG has the most promise? It was highly rated for anxiety, pain, depression, and sleep problems.
The Joint Blog
APRIL 17, 2020
But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MARCH 25, 2021
My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis.
Cannabis Law Report
AUGUST 26, 2022
Apart from this, various clinical trials are done for multiple conditions. Furthermore, CBD is often advertised to be effective for treating post-traumatic stress disorder, as well as facilitating sleep. Seizures and epilepsy are serious medical conditions. It has been predicted to reach about $47.22 Conclusion.
Veriheal
JULY 12, 2021
According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.
Veriheal
MAY 3, 2022
The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms.
Cannabis Law Report
OCTOBER 12, 2021
Diamandis joins Radicle Science as the healthtech company accelerates growth with industry veteran Sheldon Borkin PhD as CTO, the launch of a first of its kind real-world sleep study, and updates on significant milestones this year. Radicle Real World Sleep results will be announced in early 2022. “We
Expert insights. Personalized for you.
209 
Let's personalize your content